Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma
An edition of Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma (2002)
By National Institute for Clinical Excellence.
Publish Date
2002
Publisher
NICE
Language
eng
Pages
17
1-2 of 2 Editions
Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma
Language: eng
Pages: 17
Published In: 2002
Publisher: NICE
Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Language: eng
Published In: 2002
Publisher: National Institute for Clinical Excellence